| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $224.3M | +22.5% |
| Cost of Revenue | $91.1M | +29.7% |
| Gross Profit | $133.2M | +18.1% |
| R&D Expense | $3.1M | +10.3% |
| SG&A Expense | $106.2M | +20.8% |
| Operating Income | $17.9M | +24.9% |
| Pre-tax Income | $16.2M | +12.4% |
| Income Tax | $4.8M | +14.8% |
| Net Income | $11.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.5M | +36.6% |
| Accounts Receivable | $24.9M | +35.0% |
| Inventory | $4.3M | -6.7% |
| Current Assets | $52.9M | +37.8% |
| Total Assets | $177.1M | +14.3% |
| Current Liabilities | $37.3M | +16.2% |
| Long-term Debt | $3.6M | -40.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $39.1M | -13.5% |
| Capital Expenditures | $37.8M | +44.8% |
| Investing Cash Flow | -$30.7M | +41.1% |
| Financing Cash Flow | -$3.7M | -230.5% |
| Free Cash Flow | $1.3M | -93.1% |
| +10.0% |
| EPS (Basic) | $0.29 | +7.4% |
| EPS (Diluted) | $0.28 | +12.0% |
| Total Liabilities |
| $43.8M |
| +6.8% |
| Stockholders' Equity | $131.4M | +15.4% |